Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) or chemoradiotherapy (CRT) is the standard of care for patients with muscle invasive bladder cancer (MIBC). Mutations ...

Since the inception of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), approximately 68.43 lakh hospital ...

For Vancouver drag racer Cooper Chun, racing has always been an integral part of his life. It’s that lifelong passion that fueled his determination to overcome a cancer diagnosis as a teen.

The trio of nurses competing on Season 8 of “Love Is Blind” have steered clear of getting romantic with MDs — so they’re finding husbands on TV instead. “I would never date a doctor. They’re not my ...

AbbVie (NYSE: ABBV) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, ...

‎Tripoli based Libyan Prime Minister, Abdel Hamid Aldabaiba, inaugurated yesterday the launch of the foreign operation of the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Breast cancer remains a major global health challenge, with treatment strategies varying widely across regions.

Historically, cancer care largely focused on the fight for survival. Now, thanks to advancements in screening and treatment, many patients are living decades beyond their diagnosis.

Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade. Dr. Chowdhury began his presentation by emphasizing that muscle-invasive bladder cancer (MIBC) ...

Thomas Hutson, DO, PharmD, discusses key takeaways from the phase 3 CLEAR trial evaluating lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma.